Health+Benefits

Health+Benefits Sound Investment: Exploring the Economic Case for Hearing Benefits

Brokers and their clients can win by providing hearing solutions.

Sponsored By TruHearing

Health+Benefits Gene Therapy: Rarely Needed but Massively Expensive

Q&A with Ryan Siemers, Principal, Aegis Risk

One of the critiques I have of the Medicare price negotiation is that it ignored the role of PBMs in the entire debate. It basically required pharmaceutical companies to reduce the list price to a certain amount, but it didn’t say what the net price is going to be to Medicare.

Health+Benefits Who Benefits from Drug Price Negotiations?

Healthcare Costs

Q&A with Ryan Siemers, Principal, Aegis Risk

Sustaining enhanced ACA healthcare subsidies could cost hundreds of billions, bu...

Health+Benefits Threats, but Still no Replacement, to the ACA

President Trump has not detailed his “concepts of a plan” to replace Obamaca...

Health+Benefits Loneliness Lingers

Q&A with Dr. Jeremy Nobel, Professor, Harvard Medical School, and President and ...

See all Healthcare Costs

Health+Benefits Investing in Whole-Person Employee Health

Hearing benefits help employers stand out from the crowd.

Sponsored By TruHearing

Health+Benefits The Budget Hawks Are Circling

Sustaining enhanced ACA healthcare subsidies could cost hundreds of billions, but there is a way to lower that amount without forcing millions of people off coverage.

Health+Benefits Threats, but Still no Replacement, to the ACA

President Trump has not detailed his “concepts of a plan” to replace Obamacare. But legislative and regulatory changes for healthcare could still be on the horizon.

Health+Benefits Loneliness Lingers

Q&A with Dr. Jeremy Nobel, Professor, Harvard Medical School, and President and Founder, Foundation for Art & Healing